Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader?

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.
Indian Defence Review on MSN

New DNA Evidence Suggests Extinct Apex Predator May Still Roam Java’s Forests

A majestic and elusive apex predator once thought to have vanished from the wild decades ago may not be gone after all.